Center for Biomolecular and Tissue Engineering Center for Biomolecular and Tissue Engineering
Pratt School of Engineering
Duke University

 HOME > pratt > CBTE    Search Help Login pdf version printable version 

Publications [#147449] of Bruce M. Klitzman

Papers Published

  1. J Ko, J Ross, H Awad, H Hurwitz, B Klitzman, The effects of ZD6474, an inhibitor of VEGF signaling, on cutaneous wound healing in mice., The Journal of surgical research, vol. 129 no. 2 (December, 2005), pp. 251-9, ISSN 0022-4804 [doi]
    (last updated on 2013/07/01)

    Abstract:
    BACKGROUND: ZD6474 is an inhibitor of the VEGFR-2 receptor tyrosine kinase with additional activity against EGFR-1 receptor tyrosine kinases that has been shown to inhibit tumor growth and wound-induced neovascularization in pre-clinical studies and phase I clinical trials. The purpose of this study was to determine the effects of ZD6474 on breaking strength in a murine model of cutaneous wound healing. METHODS: Balb/C mice were given ZD6474 (50 or 100 mg/kg p.o.) or vehicle starting 7 days before wounding. Two full-thickness incisions were made in each mouse and closed using suture. On post-wounding day 7 or 28, laser Doppler blood flow measurements were made, and the breaking strength of the wounded skin was determined. Microvessel density measurements were performed using computer image analysis of CD31-stained sections. RESULTS: Compared with controls, mice treated with ZD6474 showed a significantly reduced dose-dependent decline in breaking strength, both at POD 7 (P < 0.001) and at POD 28 (P < 0.005). Histologically, the ZD6474-treated mice showed a qualitative reduction in the degree of fibrosis and epithelial proliferation at the wound site, but no significant difference was noted between the 50 mg/kg and 100 mg/kg ZD6474-treated groups. Also, microvessel density measurements demonstrated no significant difference between groups. CONCLUSIONS: In a murine model of wound healing, ZD6474 treatment did not prevent wound healing, but was associated with a reduced skin breaking strength compared with vehicle-treated controls at both 7 and 28 days post-wounding. These observations may have clinical relevance for the perioperative management of patients treated with inhibitors of angiogenesis.

    Keywords:
    Animals • Body Weight • Dermatologic Surgical Procedures • Female • Mice • Mice, Inbred BALB C • Microcirculation • Neovascularization, Physiologic • Piperidines • Quinazolines • Signal Transduction • Skin • Stress, Mechanical • Vascular Endothelial Growth Factor Receptor-2 • Wound Healing • Wounds and Injuries • antagonists & inhibitors* • drug effects • drug effects* • injuries* • metabolism* • pathology • pharmacology* • physiology • physiopathology*


Duke University * Pratt * CBTE * Reload * Login